CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension

CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension

Pulmonary arterial hypertension (PAH) is an increasingly frequently diagnosed disease, the molecular mechanisms of which have not been thoroughly investigated. The aim of our study was to investigate subpopulations of lymphocytes to better understand their role in the molecular pathomechanisms of va...

Full description

Bibliographic Details
Main Authors: Michał Tomaszewski, Paulina Małkowska, Olga Sierawska, Rafał Hrynkiewicz, Ewa Mroczek, Szymon Darocha, Anna Hymos, Piotr Błaszczak, Ewelina Grywalska, Paulina Niedźwiedzka-Rystwej
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:International Journal of Molecular Sciences
Subjects:
CTLA-4
pulmonary arterial hypertension
lymphocytes
Online Access:https://www.mdpi.com/1422-0067/23/24/15910

Internet

https://www.mdpi.com/1422-0067/23/24/15910

Similar Items